Drug Resistant Cell Products

The drug resistance of cancer cells is a major challenge in achieving a cure for cancer. In vitro models of drug-resistant cell lines can simulate the development of resistance to specific medications in cancer cells. These products aid in the understanding of the mechanisms behind drug resistance, facilitate the screening of targeted therapies to counteract resistance, and allow for more precise clinical treatment of related diseases. Creative Biolabs utilizes a mature cell construction platform to continuously develop high-quality drug-resistant cell line products and provide customized drug-resistant cell line services. This offers a reliable cellular research tool for cancer treatment development.

Advantages of Drug-Resistant Cell Lines

Predictive Models

Drug resistant cell lines serve as predictive models for in vivo situations, providing insights into how tumors may behave in patients receiving specific therapies. This can aid in developing personalized medicine approaches.

Biomarker Identification

By using these cell lines, our scientists can identify biomarkers associated with drug resistance that could be used to predict patient response to therapy, potentially guiding treatment decisions.

Testing New Drugs

Drug resistant cell lines are essential for screening new anticancer agents and evaluating their effectiveness against resistant tumors. They allow us to assess how new drugs perform in the context of existing resistance.

Investigating Heterogeneity

Drug-resistant cell lines can represent the heterogeneity within tumors. We can study different subpopulations of cancer cells, understanding how various genetic profiles contribute to resistance and treatment failure.

Revealing Resistance Mechanisms

Drug-resistant cell lines help clients study the biological mechanisms and genetic pathways that contribute to resistance. These data can lead to the identification of new therapeutic targets.

Validation of Combination Therapies

We can use drug-resistant cell lines to test combination therapies that might overcome resistance. This can lead to the development of more effective treatment regimens.

Featured Products

You can search for keywords to get more of our Drug-Resistant Cell Lines!

Applications of Drug-Resistant Cell Lines

Exploring Clonal Evolution
Investigate the function of a specific gene by observing how its absence affects cellular processes such as growth, differentiation, metabolism, and signaling pathways.
Drug Screening
Our drug-resistant cell lines are specifically designed for high-throughput screening assays to help clients evaluate the efficacy of new compounds. By testing drugs on resistant versus sensitive cell lines, researchers can assess how well a new agent might perform in different resistance scenarios.
Investigating Microenvironment Interactions
These cell lines offer valuable insights into the role of tumor microenvironments in drug resistance, emphasizing interactions with stromal cells, immune cells, and the extracellular matrix. By utilizing our cell lines, you can gain a better understanding of resistance mechanisms and enhance your research outcomes.
Gene Expression Profiling
Comparing drug-sensitive and drug-resistant cell lines allows for the identification of gene expression changes associated with resistance.
Personalized Medicine
We can use drug-resistant cell lines derived from patient tumors to tailor treatment strategies based on the specific resistance mechanisms in an individual's cancer, leading to more effective interventions.
Preclinical Models for Animal Studies
Cell lines can be used as a basis for creating xenograft models in animals, allowing researchers to study drug resistance in vivo. This can provide insights into how tumors will behave in a living organism and how they respond to treatment.

Target

CD19

HER2

PD-1/PD-L1

EGFR

The Procedure of Drug-Resistant Cell Lines

Cell Line Selection

Initial Drug Treatment Testing

Establishing Dosing Strategy

Isolation

Characterization

Functional Assays

Genotypic Analysis

Resistance Mechanisms Validation

Published Data

Fig.1 Generation of Drug-resistant Cell Lines. (Kannathasan, et al., 2020) Fig.1 The Figure Above Shows a Schematic of the Generation of CPT-11-R-resistant LoVo Cell lines.¹

Contact Us for More

Creative Biolabs is pleased to inform you that our biotechnology company offers a range of drug-resistant cell line products. These robust models are essential for research and development in various fields, including cancer research and pharmaceutical studies. We are committed to providing you with high-quality and reliable cell lines to support your research needs. If you have any questions or require further information, please contact us.

Reference

Kannathasan, Thetchinamoorthy, et al. "Chemoresistance-associated silencing of miR-4454 promotes colorectal cancer aggression through the GNL3L and NF-κB pathway." Cancers 12.5 (2020): 1231.Distributed under Open Access License CC BY 4.0, without modification.